BANK OF BARODA
The Investment Committee of our Bank in its meeting held today
has approved the participation of Bank of Baroda in the proposed initial public
offering of equity shares of UTI Asset Management Company Limited by way of an
offer for sale of up to 1,04,59,949 Equity Shares held by it, subject to the approval
of the Securities and Exchange Board of India (SEBI), and of any other regulatory
authority, as applicable and subject to such flexibility as may be permitted under
applicable laws, and further subject to pricing, timing and other Offer
considerations, in accordance with the SESI (Issue of Capital and Disclosure
Requirements) Regulations, 2018, as amended, the Companies Act, 2013, as
amended, including rules made thereunder and other applicable laws
KARVY
We are in receipt of an intimation from our Registrar and Share Transfer Agent, Karvy Fintech Private Limited that vide Certificate of Incorporation pursuant to change of name, the name of Karvy Fintech Private Limited has been changed to KFIN Technologies Private Limited w.e.f. December 5, 2019.
BIRLASOFT
Birlasoft honored with the ACE Alliance Award for
successful partnership with SAp®
The CK Birla Group, today announced that it has been honored with the ACE Alliance Award
2019 by SAp® for customer excellence and delivery in SAP Product Support. This honors business
excellence achieved through partnership for enabling SAP Product Support. Birlasoft received this award
at the SAP-Birlasoft partnership celebration event held at the Birlasoft office in Pune, India, in November
2019
SAP also felicitated Birlasoft as the best-running center of SAP. The recognition was done based on
evaluation of Key Performance Indicators (KPls), including consistent high-quality delivery, engagement
in next-generation support initiatives, and support beyond regular delivery. Birlasoft's partnership with
BusinessObjects for product support has its roots from 2005, even before SAP acquired BusinessObjects.
Birlasoft-SAP Product Support team has excelled in delivery and support for more than 6,000 customers
of SAP; in the Americas, Europe, Middle East, and Non-SAARC countries in 2018 alone. As a testimony of
the trust towards Birlasoft; in July 2019, SAP renewed its product support agreement for the next three
years.
"We are immensely proud to receive one of the most distinguished awards in recognition of our
contribution towards improving business processes through SAP solutions. This prestigious award
recognizes Birlasoft's continued investment in building resilient and scalable capabilities that can
effectively support SAP Products, through its expansion and growth cycles." said Vi jay Mishra, Senior
Vice President and Global Head, SAP Business, Birlasoft.
"I am pleased and honored to recognize and congratulate Birlasoft as the recipient of the ACE Alliance
Award 2019 for SAP Product Support. We look forward to closely work with Birlasoft to realize even
greater success in the years to come." said Mohammed M. Ajouz, Senior Vice President and Global
Head of Product Support, SAP.
With the cO,ntract renewed in July 2019, Birlasoft is committed to providing unparalleled and reliable
services to SAP customers. Birlasoft continues to strengthen its relationships with SAP's key customers
to minimize business disruption by reducing incident volume, incident resolution time, and automate
resolution processes, leveraging innovative digital technologies. This will help SAP's customers to not
only increase usage of SAP products, but also enable them to focus more on their core businesses.
Customer feedback received will help SAP to speed up product innovation initiatives.
JAGRAN PRAKASHAN
This is to inform you
that the Board of Directors of the Company, at its meeting held on Monday, December 09, 2019 at
01:30 p.m. which concluded at 02:30 p.m., approved the buyback of the Company's fully paid-up
equity shares having a face value of INR 2 (Indian Rupees Two Only) each (the "Equity Shares"), for
an aggregate amount not exceeding INR 1,012,500,000 (Indian Rupees One Hundred and One
Crores and Twenty-Five Lakhs Only) excluding brokerage, costs, fees, turnover charges, taxes such
as securities transaction tax, goods and service tax (if any) and income tax, stamp duty and other
incidental and related expenses ("Maximum Buyback Size") and at a price not exceeding INR 75
(Indian Rupees Seventy-Five Only) per Equity Share ("Maximum Buyback Price"), payable in cash,
from its shareholders / beneficial owners (other than those who are promoters, members of the
promoter group or persons in control), from the open market through stock exchange mechanism
i.e., using the electronic trading facilities of the stock exchanges where the equity shares of the
Company are listed i.e., National Stock Exchange of India Limited and BSE Limited, in accordance
with the provisions of the SEBI (Buy-Back of Securities) Regulations, 2018, as amended ("Buyback
Regulations") and the Companies Act, 2013 and the rules made thereunder, each as amended from
time to time ("Companies Act") (the process being referred hereinafter as "Buyback").
Before Buyback
Promoter & Promoter Group : 18,26,50,952 Qty || 61.62 %
Public : 11,37,60,877 || 38.38 %
Total : 29,64,11,829 || 100%
After Buyback
Promoter & Promoter Group : 18,26,50,952 Qty || 64.56 %
Public : 10,02,60,877 || 35.44 %
Total : 28,29,11,829 || 100%
JSW STEEL
JSW Steel Limited reports Crude Steel production at 12.90 lakh tonnes for November 2019The Blast Furnaces, which was temporarily shut down in October, 2019 due to slowdown in Auto demand has recommenced operations in the last week of November, 2019.
KILITCH DRUGS
Kilitch Drugs to set-up second green field Project in Ethiopia at
an investment of USD 5 mn
Company will manufacture liquid injectable at the proposed plant.
Company’s first unit at a critical stage, machinery installation begins;
validation to start this month & production in Q1 2020-21
Ethiopia to manufacture liquid injectables and at a capital investment
of USD 5 million. In this regard, the Company has accepted the request of Ethiopian
government for one hector land near Addis Ababa.
Kilitch Drugs has begun installing
machinery at the first Addis Ababa manufacturing unit and is all scheduled to
commence the validation process this month (December). Process validation being
an important tool in quality management of pharmaceuticals is a_ significant
parameter of GMPs. Process validation helps ensure production of drug of a
reproducible quality. Further, this also ensures that the quality assurance techniques
used to build the quality into the product at every step is up to the desired standards.
Mr. Bhavin Mehta, Whole time
Director of Kilitch Drugs said, “We are happy to announce our second
manufacturing venture in Ethiopia as also for the maiden unit which is now at
a very critical stage of our project implementation cycle. Once the validation
process is satisfactorily done, Kilitch Drugs plans to commence operations at
the first unit in the first quarter of FY2020-21. Overall, our expansion plans will
be involving a capital expenditure of Rs. 42.60 crs @ Rs. 71per USD (existing
plus incremental USD 6 mn) are as per schedule. We are confident that
manufacturing base in Ethiopia will strengthen our presence in the African
continent.”
Kilitch Drugs has registered over 300 products in key African countries and another
250+ products are under registration. It has been having a presence in Africa for
over three decades now and during this period has gained a strong advantage.
About 80% of company’s revenues come from African operations. Ethiopia has
been a center of focus for the company and it has been exporting and marketing
drug formulations in solid, liquid and parenteral dosage forms. Kilitch Drugs is bullish
on the African markets and is expecting revenues to the tune of Rs 500 crs, in the
next five years. The company’s hopes to replicate its Ethiopian business model to
the rest of Africa, going forward.
KIOCL LTD
We wish to inform that, work
agreement had been entered into between KIOCL Limited and Dept. of Mines & Geology, Govt.
of Karnataka on 6th December 2019 for carrying out Mineral Exploration by KIOCL Limited for
Manganese and Iron Ores in nine (9) identified blocks in Bellary and Chitradurga Districts of
Karnataka at a total estimated cost of Rs. 81.53 crores plus GST.
SPML INFRA
SPML Infra Ltd. received
New Project Orders worth Rs. 218 Crore
India’s leading infrastructure development company, SPML Infra Limited has received new
project orders worth Rs. 218.18 Crores. The two orders are for wastewater treatment projects in
Uttar Pradesh and Haryana from esteemed clients, Uttar Pradesh Jal Nigam, Varanasi and
Haryana State Industrial and Infrastructure Development Corporation Ltd., Bahadurgarh.
Rs. 183.68 Crore Order is for the planning, designing, engineering, procurement,
construction, testing and commissioning of 30 MLD Sewage Treatment Plant (STP) and
interception and diversion of drain in Jaunpur, Uttar Pradesh for pollution abatement of
River Ganga under the National Mission for Clean Ganga (NMCG). The project has been
received with JV partner, Pulkit Projects
Rs. 34.50 Crore Order is for the planning, designing, engineering, procurement,
construction, testing and commissioning of 10 MLD Common Effluent Treatment Plant
(CETP) and 30 MLD Main Pumping Station based on tertiary treatment for the industrial
area of Bahadurgarh.
SPARC
Abraxis Biosciences LLC has dismissed the
patent infringement complaint filed against SPARC regarding SPARC's New Drug Application
for PICS (Paclitaxel Injection Concentrate for Suspension)
Sun Pharma Advanced Research Company Ltd. (SPARC)
(Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) today announced that Abraxis
Bioscience LLC. has dismissed the patent infringement complaint filed against SPARC regarding
SPARC’s New Drug Application for PICS (Paclitaxel Injection Concentrate for Suspension).
“We are very pleased that Abraxis Bioscience LLC. has withdrawn its infringement claims paving the
way for a successful launch as and when we receive necessary regulatory approvals,” said Anil
Raghavan, CEO of SPARC.
SPARC will also inform the USFDA of the dismissal of the complaint to vacate the 30-month stay
VAKRANGEE
VAKRANGEE PARTNERS WITH UNION BANK OF INDIA FOR 20,000
BANKING BC POINTS FOR PAN INDIA NEXTGEN VAKRANGEE KENDRAS
Vakrangee Finserve Limited i.e. 100% subsidiary company of
Vakrangee Limited (VL) received approval from Union Bank of India for 20,000 Banking Business
Correspondent (BC) point for Nextgen Vakrangee Kendra.
The Bank shall allot in a batch of 2,500 BC points whereby 70-80% of BC points would be in Tier
5 and 6 locations and which would include 5% of the outlets to be opened in aspirational
districts and LWE (Left wing extremism) areas.
Nextgen Vakrangee Kendra is a standardized format outlet exclusively offering a comprehensive
range of products and services across banking, insurance, ATM, Assisted e-Commerce, eGovernance and logistics. With 70% of these Nextgen Vakrangee Kendra outlets in Tier-5 and 6
towns, Vakrangee will make available banking services to its customers in the most remote and
hitherto unserved/underserved parts of the country.
We intend to provide Banking services at these NextGen outlets along with Union Bank of India
to enable unmatched reach in remotest parts of the country as well as access to a unique
untapped customer base and help them to access the Banking services along with other
multiple services.
Also, the RBI guidelines state that the Banks need to open at least 25% of their banking outlets
in a year in unbanked area. These have to be open for at least 4 hours per day for 5 days in a
week manned either by business correspondents or by bank officials